SPINAL MUSCULAR ATROPHY TYPE 3
Clinical trials for SPINAL MUSCULAR ATROPHY TYPE 3 explained in plain language.
Never miss a new study
Get alerted when new SPINAL MUSCULAR ATROPHY TYPE 3 trials appear
Sign up with your email to follow new studies for SPINAL MUSCULAR ATROPHY TYPE 3, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for SMA babies: drug trial aims to boost motor milestones
Disease control Recruiting nowThis study tests a drug called apitegromab in babies under 2 years old who have spinal muscular atrophy (SMA), a condition that weakens muscles. The goal is to see if the drug helps improve movement skills like rolling, sitting, and crawling. All participants must already be on s…
Matched conditions: SPINAL MUSCULAR ATROPHY TYPE 3
Phase: PHASE2 • Sponsor: Scholar Rock, Inc. • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
Walking and bone health: a new study for spinal muscular atrophy
Knowledge-focused Recruiting nowThis study looks at how walking patterns are linked to bone health in people with spinal muscular atrophy (SMA) who can walk. Researchers will measure bone density, walking details, and track any falls or fractures over one year. The goal is to find simple ways to predict fractur…
Matched conditions: SPINAL MUSCULAR ATROPHY TYPE 3
Sponsor: Jacqueline Montes • Aim: Knowledge-focused
Last updated May 22, 2026 13:55 UTC
-
Smart insoles could reveal hidden clues in rare muscle diseases
Knowledge-focused Recruiting nowThis study aims to find new ways to measure walking problems in children with Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA). About 106 participants will wear special insoles that track their steps and movement during daily activities and in clinic tests. The…
Matched conditions: SPINAL MUSCULAR ATROPHY TYPE 3
Sponsor: Columbia University • Aim: Knowledge-focused
Last updated May 18, 2026 12:00 UTC